Start your intake Why Some Patients Gain Weight While Taking Zepbound Weight gain on GLP-1 therapy typically stems from one of three causes: inadequate dosing, compensatory eating behavior, or genetic variation in drug response
In fact, excessive doses often produce the opposite effect, causing paradoxical insomnia or next-day grogginess
Heres a more detailed look at its role in weight management: Administration Form: Tirzepatide is administered as a subcutaneous injection, typically once a week
Expanding Access and Lowering Costs We believe every research institution deserves access to high-quality, verified materials
Its once-weekly dosing offers convenience and consistency for those following a physician-guided weight loss plan
Your answer: If you have at least one of these conditions, youre eligible for the Medicare GLP-1 Bridge: Diastolic heart failure (also called heart failure with preserved ejection fraction) Uncontrolled high blood pressure (also called hypertension) Chronic kidney disease at stage 3a or higher Prediabetes Heart attack in the past Stroke in the past Blocked arteries in your legs or arms (peripheral artery disease) If you dont have any of these conditions, you arent eligible
